The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid
Smith, J. J., Travis, S. M., Greenberg, E. P., & Welsh, M. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81099-5 · Cited by 1,039
Cationic peptides: effectors in innate immunity and novel antimicrobials
Hancock, R. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00092-5 · Cited by 978
Self-citationThe relationship between peptide structure and antibacterial activity
Powers, J.-P. S., & Hancock, R. E. W. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.023 · Cited by 948
Self-citationCationic host defense (antimicrobial) peptides
Brown, K. L., & Hancock, R. E. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.004 · Cited by 839
Self-citationPlectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sönksen, C. P., Ludvigsen, S., Raventós, D., Buskov, S., Christensen, B., De Maria, L., et al. (2005) · Nature · doi:10.1038/nature04051 · Cited by 657
Chen, Y., Mant, C. T., Farmer, S. W., Hancock, R. E. W., Vasil, M. L., & Hodges, R. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413406200 · Cited by 600
Self-citationPolymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative Bacteria
Evans, M. E., Feola, D. J., & Rapp, R. P. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18426 · Cited by 544
Oren, Z., & Shai, Y. (1997) · Biochemistry · doi:10.1021/bi962507l · Cited by 416
Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity
Steinberg, D. A., Hurst, M. A., Fujii, C. A., Kung, A. H., Ho, J. F., Cheng, F. C., Loury, D. J., & Fiddes, J. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1738 · Cited by 384
High-throughput generation of small antibacterial peptides with improved activity
Hilpert, K., Volkmer-Engert, R., Walter, T., & Hancock, R. E. W. (2005) · Nature Biotechnology · doi:10.1038/nbt1113 · Cited by 375
Self-citationImpact of LL-37 on anti-infective immunity
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G., & Hancock, R. E. W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704380 · Cited by 374
Self-citationCan innate immunity be enhanced to treat microbial infections?
Finlay, B. B., & Hancock, R. E. W. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro908 · Cited by 298
Self-citationStructural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin
Jung, D., Rozek, A., Okon, M., & Hancock, R. E. W. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.020 · Cited by 297
Self-citationMichalopoulos, A. S., Tsiodras, S., Rellos, K., Mentzelopoulos, S., & Falagas, M. E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01043.x · Cited by 292
Antimicrobial Peptide Resistance Mechanisms of Human Bacterial Pathogens
(2006) · Current Issues in Molecular Biology · doi:10.21775/cimb.008.011 · Cited by 289
Salt-Resistant Alpha-Helical Cationic Antimicrobial Peptides
Friedrich, C., Scott, M. G., Karunaratne, N., Yan, H., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1542 · Cited by 219
Self-citationAntimicrobial peptides: therapeutic potential
Zhang, L., & Falla, T. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.6.653 · Cited by 159
Deslouches, B., Islam, K., Craigo, J. K., Paranjape, S. M., Montelaro, R. C., & Mietzner, T. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3208-3216.2005 · Cited by 159
Systemic Antibacterial Activity of Novel Synthetic Cyclic Peptides
Dartois, V. A., Sánchez‐Quesada, J., Cabezas, E., Chi, E., Dubbelde, C., Dunn, C., Granja, J. R., Gritzen, C., Weinberger, D. A., Ghadiri, M. R., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3302-3310.2005 · Cited by 157
Trotti, A., Garden, A. S., Warde, P. R., Symonds, P. R., Langer, C. J., Redman, R. L., Pajak, T. F., Fleming, T. R., Henke, M., Bourhis, J., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)01627-4 · Cited by 148
Arming the enemy: the evolution of resistance to self-proteins
Bell, G., & Gouyon, P. (2003) · Microbiology · doi:10.1099/mic.0.26265-0 · Cited by 136
Conway, S. P., Pond, M. N., Watson, A., Etherington, C., Robey, H. L., & Goldman, M. H. (1997) · Thorax · doi:10.1136/thx.52.11.987 · Cited by 136
Cottagnoud, P., Pfister, M., Acosta, F., Cottagnoud, M., Flatz, L., Kühn, F., Müller, H.-P., & Stucki, A. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3928-3933.2004 · Cited by 109
Lee, D. L., Powers, J. P. S., Pflegerl, K., Vasil, M. L., Hancock, R. E. W., & Hodges, R. S. (2004) · Journal of Peptide Research · doi:10.1046/j.1399-3011.2003.00106.x · Cited by 87
Self-citationTam, J. P., Lu, Y., & Yang, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208429200 · Cited by 59
Anti-endotoxin properties of cationic host defence peptides and proteins
Bowdish, D. M. E., & Hancock, R. E. W. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x37394 · Cited by 57
Self-citationConcerns regarding resistance to self-proteins
Hancock, R. E. W. (2003) · Microbiology · doi:10.1099/mic.0.c0122-0 · Cited by 27
Self-citation
Cited by
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
Polymeric materials with antimicrobial activity
Muñoz-Bonilla, A., & Fernández-García, M. (2012) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.08.005 · Cited by 1,221
Antibacterial Carbon‐Based Nanomaterials
Xin, Q., Shah, H., Nawaz, A., Xie, W., Akram, M. Z., Batool, A., Tian, L., Jan, S. U., Boddula, R., Guo, B., et al. (2019) · Advanced Materials · doi:10.1002/adma.201804838 · Cited by 814
Antimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 799
Metadata
- Authors
- MARR, A., GOODERHAM, W., & HANCOCK, R.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 6
- Issue
- 5
- Pages
- 468-472
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W2011615074
- Cited by
- 1,051
- References
- 30
- FWCI
- 21.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.